Clinical & Regulatory

Unlock breakthrough value by transforming your clinical and regulatory strategy

Navigating complexity. Accelerating success. Maximizing impact.

In the race to bring life-changing therapies to patients, every decision matters. Lumanity combines deep scientific, clinical, regulatory, and commercial expertise to tackle the most complex challenges in the life sciences industry.

Our integrated approach addresses critical Value Inflection Points across development and commercialization—ensuring innovations reach the market faster, meet patient needs, satisfy regulatory requirements, and deliver lasting value to stakeholders.

Our Offerings

See the path forward. Move with speed, quality, and confidence.
We help you identify critical program inflection points, create optimal development scenarios, and execute strategies that derisk pathways and support both commercial and access goals.

Early development feasibility and planning: Indication prioritization, Target Product Profile definition, integrated planning across domains

Integrated development strategy and plans: Aligning functions and stakeholders to ensure the fastest, most efficient path to market

Global regulatory strategy and plans: Navigating diverse agency requirements and market landscapes

IND readiness and gap assessments: Comprehensive cross-functional reviews (preclinical, CMC, clinical, regulatory) to ensure programs move swiftly from development to approval to patients

From first filing to final approval—and beyond.
We specialize in integrated approaches that maximize product success while minimizing approval time. Our team manages risk and unlocks value through effective engagement with health authorities, regulators, and external stakeholders.

Full-spectrum submissions: IND, BLA, NDA, DMF, CTA, MAA, and special designations (Fast Track, Breakthrough, Orphan, PRIME)

Expert agency engagement: FDA and EMA meetings: INTERACT, PIND, EOP2, CMC, preBLA/NDA

Proven success: Over 100 Advisory Committee (AdComm) and CHMP Oral Explanation meetings—more than any single large pharma

MessageAlign™ advantage: We build a unified, persuasive narrative that positions your NDA/BLA for approval success, flexes seamlessly into AdComm preparation, and extends into payer, access, and global markets—ensuring your story continues to deliver impact long after FDA review

Prevent costly delays. Protect your value.
We bring operational quality and compliance rigor that keeps your programs inspection-ready and moving forward.

GxP quality and compliance expertise: Fractional and on-demand

CMC and compliance advising: Gap analyses and targeted support

Inspection readiness and remediation: Ensuring your organization, vendors, and sites are prepared through all stages of development, preventing holds, information requests, and delays

Safeguard integrity. Maximize claims. Win in court.
We protect scientific integrity and help you turn credible evidence into compliant, market-ready product claims.

Scientific product support and claim maximization: Transforming credible scientific evidence into compelling, compliant claims that build trust, strengthen your brand, and protect you from FDA and FTC risk

Expert testimony and litigation witness preparation: Seasoned FDA regulatory experts delivering testimony and preparation that stand up under scrutiny, helping you navigate high-stakes disputes with confidence and deep industry insight

Remove roadblocks. Accelerate timelines. Improve patient impact.
Our Clinical Trial Acceleration and Remediation Framework delivers measurable improvements in trial speed, quality, and outcomes.

Trial design and protocol optimization

Site activation acceleration and PI engagement

Patient engagement and retention strategies

Challenge assessment for startup delays, operational inefficiencies, and vendor/site misalignment